Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Firmicutes |
Bacillus subtilis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riboflavin |
Click to Show/Hide the Detail |
Drug ID |
DR1416
Drug Info
|
Interaction Mechanism |
Human Tartrate-resistant acid ATPase (ACP5) and Bacillus subtilis co-metabolize the drug Riboflavin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Staphylococcus aureus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riboflavin |
Click to Show/Hide the Detail |
Drug ID |
DR1416
Drug Info
|
Interaction Mechanism |
Human Tartrate-resistant acid ATPase (ACP5) and Staphylococcus aureus co-metabolize the drug Riboflavin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Bacteria: Proteobacteria |
Salmonella typhimurium (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Riboflavin |
Click to Show/Hide the Detail |
Drug ID |
DR1416
Drug Info
|
Interaction Mechanism |
Human Tartrate-resistant acid ATPase (ACP5) and Salmonella typhimurium co-metabolize the drug Riboflavin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4], [5] |
|
|
|
|
|
|